Look for:

Our offer for

GALAPAGOS N.V.


ISIN:
BE0003818359
WKN:
-

2024/06/27 17:35:24
Price
23.34 EUR
Difference -0.26% (-0.06)

General attributes

ISINBE0003818359
SymbolGLPG
ExchangeEuronext Amsterdam
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)1,538 EUR
BenchmarkBEL 20 INDEX

Market data

Bid (Bid size)23.10 EUR (91)
Ask (Ask size)23.50 EUR (20)
Open23.40 EUR
High23.56 EUR
Low23.14 EUR
Close (prev. day)23.40 EUR
VWAP23.360264 EUR
Volume (pcs)75,776
Trading volume1,770,167.00
Number of trades714
Last size110

Futures and Options

Related Futures24
Related Options-

PDF Downloads

Company report: GALAPAGOS N.V.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/06/27 17:35:24
Price
23.34 EUR
Difference -0.26% (-0.06)

General attributes

ISINBE0003818359
SymbolGLPG
ExchangeEuronext Amsterdam
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)1,538 EUR
BenchmarkBEL 20 INDEX

Market data

Bid (Bid size)23.10 EUR (91)
Ask (Ask size)23.50 EUR (20)
Open23.40 EUR
High23.56 EUR
Low23.14 EUR
Close (prev. day)23.40 EUR
VWAP23.360264 EUR
Volume (pcs)75,776
Trading volume1,770,167.00
Number of trades714
Last size110

Performance and Risk

6m1Y3Y
Perf (%)-36.54%-37.06%-61.16%
Perf (abs.)-13.44-13.74-36.76
Beta0.380.550.80
Volatility22.8224.1033.68
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)23.84 EUR (82,158)
Ø price 30 days | Ø volume 30 days (pcs.)24.88 EUR (89,078)
Ø price 100 days | Ø volume 100 days (pcs.)28.94 EUR (86,164)
Ø price 250 days | Ø volume 250 days (pcs.)32.63 EUR (85,923)
YTD High | date39.00 EUR (2024/01/04)
YTD Low | date23.14 EUR (2024/06/27)
52 Weeks High | date40.26 EUR (2023/08/04)
52 Weeks Low | date23.14 EUR (2024/06/27)

All listings for GALAPAGOS N.V.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Vienna Stock Exchange2024/06/2709:0523.42 EUR0.003
Tradegate2024/06/2720:2423.50 EUR0.0414
Stuttgart2024/06/2713:2823.28 EUR0.002
Munich2024/06/2708:0623.72 EUR0.001
London Stock Exchange European Trade Reporting2024/06/2717:3023.40 EUR0.002
Hanover2024/06/2708:0123.34 EUR0.001
Frankfurt2024/06/2709:0723.36 EUR0.001
FINRA other OTC Issues2024/06/2118:1122.60 USD0.001
Euronext Milan MTF Trading After Hours2024/06/0618:0024.30 EUR0.001
Euronext Amsterdam2024/06/2717:3523.34 EUR1.77714
Duesseldorf2024/06/2708:1023.54 EUR0.001
Berlin2024/06/2719:3323.42 EUR0.0015

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=124785&ID_TYPE_IMAGE_LOGO=2

Contact Details

GALAPAGOS NV
- -
Industriepark Mechelen Noord, Generaal de Wittelaan L11 A3 - 2800 Mechelen
Telefon: +32-1-534-29-00
Fax: +
E-mail: -

PDF Downloads

Company report: GALAPAGOS N.V.PDF Download

Company Profile

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.

Members of Management Board

Paul StoffelsChairman of Managing Board
Annelies MissottenMember of Executive Committee
Thad HustonMember of Executive Committee
Valeria CnossenMember of Executive Committee

Board of directors

Dan BakerMember of Supervisory Board
Lena Elisabeth SvanbergMember of Supervisory Board
Linda HigginsMember of Supervisory Board
Simon SturgeMember of Supervisory Board
Susanne Antonie SchaffertMember of Supervisory Board
Andrew DickinsonMember of Supervisory Board
Jérôme ContamineMember of Supervisory Board
Peter GuenterMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer